A CRISPR Breakthrough: Removing the Extra Chromosome 21 in Down Syndrome Cells
Dr. M A Mujeeb | @muzeeb_7/X A CRISPR Breakthrough: Removing the Extra Chromosome 21 in Down Syndrome Cells In a landmark development that could reshape the future of genetic medicine, researchers in Japan have successfully used CRISPR-Cas9 genome editing to remove the extra copy of chromosome 21, the root cause of Down syndrome from human cells. This breakthrough, though still in its early stages, opens new avenues for understanding and potentially treating trisomy 21 at its genetic core. (AI generated representation of gene therapy by CRISPR-Cas9) 🔍 The Science Behind the Innovation Down syndrome, or trisomy 21, arises when an individual inherits three copies of chromosome 21 instead of the usual two. This genetic anomaly leads to a spectrum of developmental, cognitive, and health challenges. Until now, therapeutic strategies have focused on managing symptoms not correcting the underlying genetic cause. That changed with a recent study led by Dr. Ryotaro Hashizume and his team ...